Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Depression, anxiety and loneliness in later life

Medicine of older adults · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Suicide, self-neglect or life-threatening depression

Active suicide intent, plan or means, psychotic depression, refusal of essential intake, severe self-neglect, catatonia or inability to remain safe requires same-day mental-health and medical care rather than routine screening follow-up.

Action: Stay with the person when immediate risk is high, remove accessible means proportionately, assess physical illness, delirium, capacity and safeguarding, contact urgent mental-health services and consider admission and rapid specialist treatment including ECT when indicated.

Synopsis

Recognise later-life depression and anxiety behind cognitive, physical and functional presentations, assess suicide and safeguarding directly, distinguish loneliness without medicalising it, and combine accessible psychological, social and medicine care with physical-comorbidity safeguards.

  • Later-life depression may present as loss of interest, fatigue, pain, poor appetite, sleep change, memory complaint, irritability or functional withdrawal rather than stated sadness.
  • First-line assessment combines direct interview, collateral and a validated tool such as PHQ-9 or GDS; a score neither diagnoses nor assesses suicide alone.
  • Ask directly about suicide at initial and follow-up review. Do not assume older age, faith, family presence or bereavement makes risk low.
  • Use 4AT for acute change and assess cognition, physical disease, pain, sleep, alcohol, medicines, hearing, vision, grief, abuse and practical adversity.
  • Loneliness is subjective disconnection; living alone is an objective arrangement. Neither automatically means depression, and social contact must match the person's preference.
  • For less severe depression, first-line options include guided self-help, behavioural activation, structured exercise and psychological treatment chosen with the person.
  • For more severe depression, NICE supports individual CBT plus an antidepressant when acceptable, with urgent specialist care for psychosis, catatonia or life-threatening intake failure.
  • A cautious frail-adult sertraline regimen may start 25 mg daily and increase to 50 mg after about one week, with sodium, bleeding and falls review.
  • Mirtazapine may suit selected insomnia or low-appetite phenotypes but sedation and posture can worsen falls; it is an antidepressant, not a social treatment for loneliness.
  • Address hearing, transport, digital exclusion, bereavement, carer role and meaningful group or one-to-one connection alongside clinical therapy.

Key red flags

Ask directly about thoughts of death, self-harm, intent, plan, means, previous attempts, substance use, protective factors and current ability to remain safe.

New confusion, altered arousal or abrupt withdrawal is delirium until assessed and cannot be diagnosed as depression from a questionnaire.

Psychotic guilt, nihilistic delusion, starvation, stupor or severe psychomotor change requires urgent old-age psychiatry assessment.

Anxiety with chest pain, syncope, focal neurology, hypoxia, hypoglycaemia or thyroid symptoms needs parallel medical evaluation.

Bereavement does not protect against major depression or suicide; assess duration, pervasive symptoms, function, guilt and hopelessness.

Financial control, isolation by others, neglect or fear at home raises safeguarding concern rather than uncomplicated loneliness.

High suicide risk

Intent, plan, means, psychosis, severe hopelessness or inability to maintain safety requires immediate action.

Psychotic or catatonic depression

Nihilistic guilt, hallucination, stupor, mutism or refusal of intake requires urgent specialist treatment.

Investigation priorities

01
Clinical mood and anxiety interviewFirst step

Establish syndrome, chronology and function.

Management branches

First-line assessmentDiagnose, assess risk and find contributors

Persistent low mood, anxiety, withdrawal, somatic or cognitive complaint occurs.

  1. Optimise communication and assess suicide, psychosis, mania, delirium and immediate medical danger.
  2. Use clinical interview, collateral and validated screening with functional, medicine, physical and social assessment.
  3. Agree severity, goals and a psychological, social and if appropriate medicine plan with early review.

Key medicines

SertralineFor a sensitive or frail older adult, start 25 mg orally once daily and increase to 50 mg after about one week if tolerated; later increases follow response, adverse effects and product-guided maximum dosing.Review early activation and suicide, hyponatraemia, GI effects, bleeding with antithrombotics or NSAIDs, falls, serotonin interactions, hepatic impairment and gradual withdrawal.
MirtazapineStart 15 mg orally at night and consider 30 mg after one to two weeks according to response and tolerance; the licensed maximum is 45 mg once daily.Sedation, dizziness, posture and weight gain can harm mobility; review mania risk and withdrawal and obtain urgent FBC for fever, sore throat or other neutropenia symptoms.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG222 depression in adultsAssessment, suicide risk, psychological and antidepressant treatment.
  • NICE CG113 anxiety and panic disorderAnxiety assessment, CBT and medicine principles.
  • NICE NG32 older people mental wellbeingIndependence, meaningful activity and social participation.
  • NICE TA59 electroconvulsive therapyECT indications, consent, risks and review.
  • NICE CG103 delirium recommendationsAcute withdrawal and cognitive change.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom